Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Feature selection using factor analysis for Alzheimer's diagnosis using 18F-FDG PET images.

Salas-Gonzalez D, Górriz JM, Ramírez J, Illán IA, López M, Segovia F, Chaves R, Padilla P, Puntonet CG.

Med Phys. 2010 Nov;37(11):6084-95.

2.

Feature selection using factor analysis for Alzheimer's diagnosis using F18-FDG PET images.

Salas-Gonzalez D, Górriz JM, Ramírez J, Illán IA, López M, Segovia F, Chaves R, Padilla P, Puntonet CG; Alzheimer's Disease Neuroimage Initiative.

Med Phys. 2010 Nov;37(11):6084-6095. doi: 10.1118/1.3488894.

PMID:
28525009
3.

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, Li Y, Boppana M, de Leon MJ.

Neurology. 2005 Jun 14;64(11):1860-7.

PMID:
15955934
4.

Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.

Ota K, Oishi N, Ito K, Fukuyama H; SEAD-J Study Group; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci Methods. 2015 Dec 30;256:168-83. doi: 10.1016/j.jneumeth.2015.08.020. Epub 2015 Aug 28.

5.

Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.

Ito K, Shimano Y, Imabayashi E, Nakata Y, Omachi Y, Sato N, Arima K, Matsuda H.

Int J Geriatr Psychiatry. 2014 Oct;29(10):1079-86. doi: 10.1002/gps.4102. Epub 2014 Mar 29.

PMID:
24687634
6.

Classification of Alzheimer's disease from FDG-PET images using favourite class ensembles.

Cabral C, Silveira M; Alzheimer’s Disease Neuroimaging Initiative.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:2477-80. doi: 10.1109/EMBC.2013.6610042.

PMID:
24110229
7.

Multimodal classification of Alzheimer's disease and mild cognitive impairment.

Zhang D, Wang Y, Zhou L, Yuan H, Shen D; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Apr 1;55(3):856-67. doi: 10.1016/j.neuroimage.2011.01.008. Epub 2011 Jan 12.

8.

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.

Apostolova LG, Hwang KS, Kohannim O, Avila D, Elashoff D, Jack CR Jr, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.

9.

Longitudinal FDG-PET features for the classification of Alzheimer's disease.

Rodrigues F, Silveira M.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:1941-4. doi: 10.1109/EMBC.2014.6943992.

PMID:
25570360
10.

Inter-modality relationship constrained multi-modality multi-task feature selection for Alzheimer's Disease and mild cognitive impairment identification.

Liu F, Wee CY, Chen H, Shen D.

Neuroimage. 2014 Jan 1;84:466-75. doi: 10.1016/j.neuroimage.2013.09.015. Epub 2013 Sep 14.

11.

Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.

Habeck C, Risacher S, Lee GJ, Glymour MM, Mormino E, Mukherjee S, Kim S, Nho K, DeCarli C, Saykin AJ, Crane PK; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Dec;6(4):568-83. doi: 10.1007/s11682-012-9208-x.

12.

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.

Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S, Diehl-Schmid J, Perneczky R, Clerici F, Caselli R, Beuthien-Baumann B, Kurz A, Minoshima S, de Leon MJ.

J Nucl Med. 2008 Mar;49(3):390-8. doi: 10.2967/jnumed.107.045385. Epub 2008 Feb 20.

13.

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 May 1;45(4):1107-16. doi: 10.1016/j.neuroimage.2008.12.072. Epub 2009 Jan 21.

14.

Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.

Zhan Y, Chen K, Wu X, Zhang D, Zhang J, Yao L, Guo X; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(4):1057-67. doi: 10.3233/JAD-142820.

PMID:
26401783
15.

Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.

Arbizu J, Prieto E, Martínez-Lage P, Martí-Climent JM, García-Granero M, Lamet I, Pastor P, Riverol M, Gómez-Isla MT, Peñuelas I, Richter JA, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1394-405. doi: 10.1007/s00259-013-2458-z. Epub 2013 May 29.

PMID:
23715905
16.

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.

Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Någren K, Kim BC, Tsui W, de Leon MJ.

Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2169-81. doi: 10.1007/s00259-008-0833-y. Epub 2008 Jun 20.

17.

Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years.

Pardo JV, Lee JT, Kuskowski MA, Munch KR, Carlis JV, Sheikh SA, Surerus C, Lewis SM, McCarten JR, Fink H, McPherson S, Shah HH, Rottunda S, Dysken MW.

Alzheimers Dement. 2010 Jul;6(4):326-33. doi: 10.1016/j.jalz.2009.09.005. Epub 2010 May 6.

18.

Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.

Pagani M, De Carli F, Morbelli S, Öberg J, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A, van Berckel BN, Ossenkoppele R, Didic M, Guedj E, Brugnolo A, Picco A, Arnaldi D, Ferrara M, Buschiazzo A, Sambuceti G, Nobili F.

Neuroimage Clin. 2014 Nov 18;7:34-42. doi: 10.1016/j.nicl.2014.11.007. eCollection 2015.

19.

Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.

Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, Goldhardt O, Ortner M, Sorg C, Kurz A.

J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19.

20.

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease.

Li R, Perneczky R, Yakushev I, Förster S, Kurz A, Drzezga A, Kramer S; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2015 Apr 28;10(4):e0122731. doi: 10.1371/journal.pone.0122731. eCollection 2014.

Supplemental Content

Support Center